Virpax Pharmaceuticals's total assets for Q2 2023 were $15.95M, a decrease of -13.75% from the previous quarter. VRPX total liabilities were $3.65M for the fiscal quarter, a 10.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.